Smith & Nephew PLC ADR (SNN): Price and Financial Metrics

SNN POWR Grades

• Sentiment is the dimension where SNN ranks best; there it ranks ahead of 93.73% of US stocks.
• The strongest trend for SNN is in Growth, which has been heading up over the past 179 days.
• SNN ranks lowest in Quality; there it ranks in the 57th percentile.

SNN Stock Summary

• SMITH & NEPHEW PLC's market capitalization of $13,274,449,973 is ahead of 86.94% of US-listed equities.
• With a one year PEG ratio of 2,619.17, SMITH & NEPHEW PLC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 98.93% of US stocks.
• SNN's current price/earnings ratio is 59.53, which is higher than 90.6% of US stocks with positive earnings.
• Stocks with similar financial metrics, market capitalization, and price volatility to SMITH & NEPHEW PLC are SCPL, CCJ, PNR, EBMT, and ATKR.
• Visit SNN's SEC page to see the company's official filings. To visit the company's web site, go to www.smith-nephew.com.

SNN Valuation Summary

• SNN's price/sales ratio is 2.6; this is 18.18% higher than that of the median Healthcare stock.
• SNN's price/earnings ratio has moved up 48.6 over the prior 243 months.

Below are key valuation metrics over time for SNN.

SNN Growth Metrics

Its year over year net cashflow from operations growth rate is now at 7.82%.
• Its 5 year net cashflow from operations growth rate is now at 32.37%.
• The year over year net income to common stockholders growth rate now stands at 16.96%.

The table below shows SNN's growth in key financial areas (numbers in millions of US dollars).

SNN's Quality Factors

• SNN has a Quality Grade of B, ranking ahead of 77.5% of graded US stocks.
• SNN's asset turnover comes in at 0.445 -- ranking 108th of 186 Medical Equipment stocks.
• HOLX, TTOO, and BIOL are the stocks whose asset turnover ratios are most correlated with SNN.

The table below shows SNN's key quality metrics over time.